Redsense Medical AB (FRA:R0Z) Tariff Resilience Score: 0/10 (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:R0Z Redsense Medical AB FRA:R0Z
54 GF Score
Price €0.33
GF Value €0.58
! 5 Warning Signs
View Full Analysis

What is Redsense Medical AB Tariff Resilience Score?

Redsense Medical AB has the Tariff Resilience Score of 0, which implies that the company might have .

Redsense Medical AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Redsense Medical AB might have .

Redsense Medical AB  (FRA:R0Z) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Redsense Medical AB Tariff Resilience Score Related Terms

FRA:R0Z
54GF Score
Redsense Medical AB FRA:R0Z
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Redsense Medical AB (FRA:R0Z) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of €0.33 is trading 43.1% below its estimated GF Value™ of €0.58.

Key valuation signals for FRA:R0Z:

  • Tariff Resilience Score: 0
  • GF Value™: €0.58 vs. price of €0.33 (43.1% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the FRA:R0Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redsense Medical AB Business Description

Other Exchanges REDS:Sweden
Address Storgatan 36, Halmstad, SWE, 302 43
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score

Get the complete analysis for FRA:R0Z

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.33
Price
€0.58
GF Value